Operant sensation seeking requires metabotropic glutamate receptor 5 (mGluR5)

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Olsen, Christopher M ^a,b   Childs, Daniel S ^a   Stanwood, Gregg D ^a,b   Winder, Danny G ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; HETEROZYGOSITY; INSTRUMENTAL CONDITIONING; KNOCKOUT MOUSE; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; PLACE PREFERENCE; PROTEIN FUNCTION; REINFORCEMENT; WILD TYPE; ANIMAL; C57BL MOUSE; DRUG EFFECT; DRUG SELF ADMINISTRATION; FEMALE; GENETICS; GENOTYPE; MOTOR ACTIVITY; MOUSE MUTANT; PHYSIOLOGY; SENSATION;

MUS;

ANIMALS; COCAINE; CONDITIONING, OPERANT; FEMALE; GENOTYPE; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; RECEPTORS, METABOTROPIC GLUTAMATE; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; SENSATION; VASOCONSTRICTOR AGENTS;

EID: 78649785280     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015085     Document Type: Article

References (46)

1. Marino MJ, Conn PJ (2006) Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors. Curr Opin Pharmacol 6: 98-102.
2. Olive MF (2009) Metabotropic glutamate receptor ligands as potential therapeutics for addiction. Curr Drug Abuse Rev 2: 83-989.
3. Palucha A, Pilc A (2007) Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs. Pharmacol Ther 115: 116-147.
4. Swanson CJ, Bures M, Johnson MP, Linden AM, Monn JA, et al. (2005) Metabotropic glutamate receptors as novel targets for anxiety and stress disorders. Nat Rev Drug Discov 4: 131-144.
5. Carroll FI (2008) Antagonists at metabotropic glutamate receptor subtype 5: structure activity relationships and therapeutic potential for addiction. Ann N Y Acad Sci 1141: 221-232.
6. Conn PJ, Jones CK, Lindsley CW (2009) Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders. Trends Pharmacol Sci 30: 148-155.
7. Chiamulera C, Epping-Jordan MP, Zocchi A, Marcon C, Cottiny C, et al. (2001) Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci 4: 873-874.
8. Gass JT, Osborne MP, Watson NL, Brown JL, Olive MF (2009) mGluR5 antagonism attenuates methamphetamine reinforcement and prevents reinstatement of methamphetamine-seeking behavior in rats. Neuropsychopharmacology 34: 820-833.
9. Heilig M, Egli M (2006) Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol Ther 111: 855-876.
10. Olive MF, McGeehan AJ, Kinder JR, McMahon T, Hodge CW, et al. (2005) The mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine decreases ethanol consumption via a protein kinase C epsilon-dependent mechanism. Mol Pharmacol 67: 349-355.
11. Paterson NE, Markou A (2005) The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats. Psychopharmacology 179: 255-261.
12. van der Kam EL, de Vry J, Tzschentke TM (2007) Effect of 2-methyl-6- (phenylethynyl) pyridine on intravenous self-administration of ketamine and heroin in the rat. Behav Pharmacol 18: 717-724.
13. Backstrom P, Bachteler D, Koch S, Hyytia P, Spanagel R (2004) MGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior. Neuropsychopharmacology 29: 921-928.
14. Kumaresan V, Yuan M, Yee J, Famous KR, Anderson SM, et al. (2009) Metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate cocaine priming- and cue-induced reinstatement of cocaine seeking. Behav Brain Res 202: 238-244.
15. Martin-Fardon R, Baptista MA, Dayas CV, Weiss F (2009) Dissociation of the effects of MTEP [3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]piperidine] on conditioned reinstatement and reinforcement: comparison between cocaine and a conventional reinforcer. J Pharmacol Exp Ther 329: 1084-1090.
16. Platt DM, Rowlett JK, Spealman RD (2008) Attenuation of cocaine selfadministration in squirrel monkeys following repeated administration of the mGluR5 antagonist MPEP: comparison with dizocilpine. Psychopharmacology (Berl) 200: 167-176.
17. Bisaga A, Danysz W, Foltin RW (2008) Antagonism of glutamatergic NMDA and mGluR5 receptors decreases consumption of food in baboon model of binge-eating disorder. Eur Neuropsychopharmacol 18: 794-802.
18. Olsen CM, Winder DG (In production) Operant sensation seeking in the mouse. Journal of Visualized Experiments, doi: 103791/2292.
19. Olsen CM, Winder DG (2009) Operant sensation seeking engages similar neural substrates to operant drug seeking in C57 mice. Neuropsychopharmacology 34: 1685-1694.
20. Cain ME, Green TA, Bardo MT (2006) Environmental enrichment decreases responding for visual novelty. Behavioural Processes 73: 360-366.
21. Stewart J (1960) Reinforcing effects of light as a function of intensity and reinforcement schedule. Journal of comparative and physiological psychology 53: 187-193.
22. Blatter K, Schultz W (2006) Rewarding properties of visual stimuli. Exp Brain Res 168: 541-546.
23. Baron A, Kish GB (1962) Low-intensity auditory and visual stimuli as reinforcers for the mouse. J Comp Physiol Psychol 55: 1011-1013.
24. Thompson TI (1963) Visual Reinforcement in Siamese Fighting Fish. Science 141: 55-57.
25. Bird MK, Reid CA, Chen F, Tan HO, Petrou S, et al. (2010) Cocaine-mediated synaptic potentiation is absent in VTA neurons from mGlu5-deficient mice. Int J Neuropsychopharmacol 13: 133-141.
26. Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463: 3-33.
27. Bradbury MJ, Campbell U, Giracello D, Chapman D, King C, et al. (2005) Metabotropic glutamate receptor mGlu5 is a mediator of appetite and energy balance in rats and mice. J Pharmacol Exp Ther 313: 395-402.
28. Caine SB, Thomsen M, Gabriel KI, Berkowitz JS, Gold LH, et al. (2007) Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice. J Neurosci 27: 13140-13150.
29. Pogorelov VM, Rodriguiz RM, Insco ML, Caron MG, Wetsel WC (2005) Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene. Neuropsychopharmacology 30: 1818-1831.
30. Bird MK, Kirchhoff J, Djouma E, Lawrence AJ (2008) Metabotropic glutamate 5 receptors regulate sensitivity to ethanol in mice. Int J Neuropsychopharmacol 11: 765-774.
31. Miner LL, Drago J, Chamberlain PM, Donovan D, Uhl GR (1995) Retained cocaine conditioned place preference in D1 receptor deficient mice. Neuroreport 6: 2314-2316.
32. O'Connor EC, Crombag HS, Mead AN, Stephens DN (2010) The mGluR5 Antagonist MTEP Dissociates the Acquisition of Predictive and Incentive Motivational Properties of Reward-Paired Stimuli in Mice. Neuropsychopharmacology.
33. Spooren W, Gasparini F (2004) mGlu5 receptor antagonists: a novel class of anxiolytics? Drug News Perspect 17: 251-257.
34. Brodkin J, Bradbury M, Busse C, Warren N, Bristow LJ, et al. (2002) Reduced stress-induced hyperthermia in mGluR5 knockout mice. Eur J Neurosci 16: 2241-2244.
35. Pecknold JC, McClure DJ, Appeltauer L, Wrzesinski L, Allan T (1982) Treatment of anxiety using fenobam (a nonbenzodiazepine) in a double-blind standard (diazepam) placebo-controlled study. J Clin Psychopharmacol 2: 129-133.
36. Lapierre YD, Oyewumi LK (1982) Fenobam: another anxiolytic? Curr Ther Res 31: 95-101.
37. Schumann G, Johann M, Frank J, Preuss U, Dahmen N, et al. (2008) Systematic analysis of glutamatergic neurotransmission genes in alcohol dependence and adolescent risky drinking behavior. Arch Gen Psychiatry 65: 826-838.
38. Kinney GG, Burno M, Campbell UC, Hernandez LM, Rodriguez D, et al. (2003) Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents. J Pharmacol Exp Ther 306: 116-123.
39. Lu YM, Jia Z, Janus C, Henderson JT, Gerlai R, et al. (1997) Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J Neurosci 17: 5196-5205.
40. Olsen CM, Winder DG (2006) A method for single-session cocaine selfadministration in the mouse. Psychopharmacology (Berl) 187: 13-21.
41. Grueter BA, Gosnell HB, Olsen CM, Schramm-Sapyta NL, Nekrasova T, et al. (2006) Extracellular-signal regulated kinase 1-dependent metabotropic glutamate receptor 5-induced long-term depression in the bed nucleus of the stria terminalis is disrupted by cocaine administration. J Neurosci 26: 3210-3219.
42. Schramm-Sapyta NL, Olsen CM, Winder DG (2006) Cocaine self-administration reduces excitatory responses in the mouse nucleus accumbens shell. Neuropsychopharmacology 31: 1444-1451.
43. Colby CR, Whisler K, Steffen C, Nestler EJ, Self DW (2003) Striatal cell typespecific overexpression of DeltaFosB enhances incentive for cocaine. J Neurosci 23: 2488-2493.
44. Cunningham CL, Ferree NK, Howard MA (2003) Apparatus bias and place conditioning with ethanol in mice. Psychopharmacology (Berl) 170: 409-422.
45. Irwin S (1968) Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 13: 222-257.
46. Holmes A, Kinney JW, Wrenn CC, Li Q, Yang RJ, et al. (2003) Galanin GALR1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze. Neuropsychopharmacology 28: 1031-1044.